Pay in 4 interest-free payments of $6.85 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Read the full article in Journal of Substance Abuse Treatment: Learn more about the implementation research in addiction: #ImplementationScience #AddictionResearch #EvidenceBased #NIH #NIDA #PublicHealth #ResearchToPractice To view or add a comment, sign in GLP-1 drugs, originally developed for diabetes and obesity, may also curb addictive behaviors by acting on reward circuits in the brain
We provide it in a supervised context as a recovery-support option
Tanabe, S., et al
Furthermore, the high price of GLP-1 drugs and restricted insurance coverage create accessibility challenges, particularly in lower-income populations
The most frequent side effects are gastrointestinal, including nausea, constipation, and appetite loss, which typically diminish as your body adapts
US$ 24.69
US$ 22.53
US$ 20.67
US$ 22.20
